Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Drug Toxicity: Risk factors
Renal Failure: Dose Adjustments
Acute Kidney Injury I: Introduction
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Drug toxicity: Idiosyncratic Reactions
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 26, 2026

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
Published on: October 23, 2019
Allon Kahn1, Jennifer L Horsley-Silva1, Dora M Lam-Himlin2
1a Division of Gastroenterology and Hepatology , Mayo Clinic , Phoenix , AZ , USA.
No abstract available in PubMed .
09:32Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
Published on: October 17, 2025
12:40A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
Published on: December 7, 2014